138 related articles for article (PubMed ID: 15794854)
1. Cytogenetics of familial Waldenstrom's macroglobulinemia: in pursuit of an understanding of genetic predisposition.
McMaster ML; Giambarresi T; Vasquez L; Goldstein AM; Tucker MA
Clin Lymphoma; 2005 Mar; 5(4):230-4. PubMed ID: 15794854
[TBL] [Abstract][Full Text] [Related]
2. Novel aspects pertaining to the relationship of Waldenström's macroglobulinemia, IgM monoclonal gammopathy of undetermined significance, polyclonal gammopathy, and hypoglobulinemia.
McMaster ML; Kristinsson SY; Turesson I; Björkholm M; Landgren O
Clin Lymphoma Myeloma; 2009 Mar; 9(1):19-22. PubMed ID: 19362963
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenström's macroglobulinemia and IgM monoclonal gammopathy of undetermined significance.
Martín-Jiménez P; García-Sanz R; Balanzategui A; Alcoceba M; Ocio E; Sanchez ML; González M; San Miguel J
Haematologica; 2007 May; 92(5):635-42. PubMed ID: 17488687
[TBL] [Abstract][Full Text] [Related]
4. Familial Waldenstrom's macroglobulinemia.
McMaster ML
Semin Oncol; 2003 Apr; 30(2):146-52. PubMed ID: 12720125
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin heavy chain sequence analysis in Waldenstrom's macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance.
Rollett RA; Wilkinson EJ; Gonzalez D; Fenton JA; Short MA; Evans PA; Rawstron AC; Owen RG
Clin Lymphoma Myeloma; 2006 Jul; 7(1):70-2. PubMed ID: 16879773
[TBL] [Abstract][Full Text] [Related]
6. Characterization of familial Waldenstrom's macroglobulinemia.
Treon SP; Hunter ZR; Aggarwal A; Ewen EP; Masota S; Lee C; Santos DD; Hatjiharissi E; Xu L; Leleu X; Tournilhac O; Patterson CJ; Manning R; Branagan AR; Morton CC
Ann Oncol; 2006 Mar; 17(3):488-94. PubMed ID: 16357024
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetic aberrations in neuropathy associated with IgM monoclonal gammopathy.
Eurelings M; Lokhorst HM; Notermans NC; Krijtenburg PJ; Kessel Bv; Eleveld MJ; Bloem A; Wokke JH; Poot M; Buijs A
J Neurol Sci; 2007 Sep; 260(1-2):124-31. PubMed ID: 17543994
[TBL] [Abstract][Full Text] [Related]
8. Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstrom's macroglobulinemia, multiple myeloma, and IgM monoclonal gammopathy of undetermined significance.
Pilarski LM; Andrews EJ; Serra HM; Ledbetter JA; Ruether BA; Mant MJ
Am J Hematol; 1989 Feb; 30(2):53-60. PubMed ID: 2536515
[TBL] [Abstract][Full Text] [Related]
9. Genetics and cytogenetics of Waldenstrom's macroglobulinemia.
Schop RF; Fonseca R
Semin Oncol; 2003 Apr; 30(2):142-5. PubMed ID: 12720124
[TBL] [Abstract][Full Text] [Related]
10. 6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance.
Schop RF; Van Wier SA; Xu R; Ghobrial I; Ahmann GJ; Greipp PR; Kyle RA; Dispenzieri A; Lacy MQ; Rajkumar SV; Gertz MA; Fonseca R
Cancer Genet Cytogenet; 2006 Sep; 169(2):150-3. PubMed ID: 16938573
[TBL] [Abstract][Full Text] [Related]
11. Waldenström's macroglobulinemia in monozygotic twins.
Fine JM; Muller JY; Rochu D; Marneux M; Gorin NC; Fine A; Lambin P
Acta Med Scand; 1986; 220(4):369-73. PubMed ID: 3099545
[TBL] [Abstract][Full Text] [Related]
12. Familial Waldenström Macroglobulinemia: Families Informing Populations.
McMaster ML
Hematol Oncol Clin North Am; 2018 Oct; 32(5):787-809. PubMed ID: 30190018
[TBL] [Abstract][Full Text] [Related]
13. 14q32 Translocations discriminate IgM multiple myeloma from Waldenstrom's macroglobulinemia.
Avet-Loiseau H; Garand R; Lodé L; Robillard N; Bataille R
Semin Oncol; 2003 Apr; 30(2):153-5. PubMed ID: 12720126
[TBL] [Abstract][Full Text] [Related]
14. Familial predisposition to monoclonal gammopathy of unknown significance, Waldenström's macroglobulinemia, and multiple myeloma.
Ogmundsdóttir HM; Einarsdóttir HK; Steingrímsdóttir H; Haraldsdóttir V
Clin Lymphoma Myeloma; 2009 Mar; 9(1):27-9. PubMed ID: 19362965
[TBL] [Abstract][Full Text] [Related]
15. Familial Waldenstrom's macroglobulinemia and relation to immune defects, autoimmune diseases, and haematological malignancies--A population-based study from northern Sweden.
Brandefors L; Kimby E; Lundqvist K; Melin B; Lindh J
Acta Oncol; 2016; 55(1):91-8. PubMed ID: 26559865
[TBL] [Abstract][Full Text] [Related]
16. Origins of Waldenstrom's macroglobulinemia: does it arise from an unusual B-cell precursor?
Kriangkum J; Taylor BJ; Reiman T; Belch AR; Pilarski LM
Clin Lymphoma; 2005 Mar; 5(4):217-9. PubMed ID: 15794851
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotypic and cytogenetic comparison of Waldenstrom's macroglobulinemia with splenic marginal zone lymphoma.
Ocio EM; Hernandez JM; Mateo G; Sanchez ML; Gonzalez B; Vidriales B; Gutierrez NC; Orfao A; San Miguel JF
Clin Lymphoma; 2005 Mar; 5(4):241-5. PubMed ID: 15794856
[TBL] [Abstract][Full Text] [Related]
18. A case-control and family study of Waldenstrom's macroglobulinemia.
Linet MS; Humphrey RL; Mehl ES; Brown LM; Pottern LM; Bias WB; McCaffrey L
Leukemia; 1993 Sep; 7(9):1363-9. PubMed ID: 8371587
[TBL] [Abstract][Full Text] [Related]
19. Familial paraproteinemia: hyper-responsive B-cells as endophenotype.
Ögmundsdóttir HM; Steingrímsdóttir H; Haraldsdóttir V
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):82-4. PubMed ID: 21454198
[TBL] [Abstract][Full Text] [Related]
20. Hyperphosphorylated paratarg-7: a new molecularly defined risk factor for monoclonal gammopathy of undetermined significance of the IgM type and Waldenstrom macroglobulinemia.
Grass S; Preuss KD; Wikowicz A; Terpos E; Ziepert M; Nikolaus D; Yang Y; Fadle N; Regitz E; Dimopoulos MA; Treon SP; Hunter ZR; Pfreundschuh M
Blood; 2011 Mar; 117(10):2918-23. PubMed ID: 21220746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
